Robert Freishtat

Robert Freishtat, M.D., M.P.H., is the Chief Scientific Officer and Co-Founder of Adipomics, a company focused on advancing research in the field of obesity and metabolic diseases. He is also recognized for his extensive contributions to pediatric medicine and research.

Professional Background

Dr. Freishtat has a robust background in medicine and research. He previously served as the Chief Biotechnology Officer at Children's National Hospital, where he established the Office of Biotechnology to foster innovation and expedite the development of novel medical solutions for children. He has been involved in significant research collaborations and has authored over 140 publications in areas such as lung injury, asthma, and obesity.23

In addition to his role at Adipomics, he is a Professor with Tenure in Pediatrics, Emergency Medicine, Genomics, and Precision Medicine at The George Washington University School of Medicine and Health Sciences. His leadership in the field was further acknowledged when he was appointed as the first Connor Family Professor in Research and Innovation at Children's National Hospital in 2022.23

Education

Dr. Freishtat earned his medical degree from the University of Maryland, Baltimore, and a Master of Public Health from The George Washington University, specializing in biostatistics and epidemiology. He completed his residency in pediatrics at the University of Rochester and a fellowship in Pediatric Emergency Medicine at Children's National Hospital.12

Contributions and Impact

Through his work, Dr. Freishtat has significantly impacted healthcare, particularly in pediatric settings. He has led initiatives that integrate innovative research with clinical practice, aiming to improve patient outcomes and advance the field of pediatric medicine. His commitment to addressing childhood obesity and related health issues is central to his work at Adipomics.123